Literature DB >> 34973458

Roles of clock genes in the pathogenesis of Parkinson's disease.

Anastasiia Dmytrivna Shkodina1, Shing Cheng Tan2, Mohammad Mehedi Hasan3, Mai Abdelgawad4, Hitesh Chopra5, Muhammad Bilal6, Dmytro Ivanovych Boiko1, Kateryna Anatoliivna Tarianyk1, Athanasios Alexiou7.   

Abstract

Parkinson's disease (PD) is a common motor disorder that has become increasingly prevalent in the ageing population. Recent works have suggested that circadian rhythms disruption is a common event in PD patients. Clock genes regulate the circadian rhythm of biological processes in eukaryotic organisms, but their roles in PD remain unclear. Despite this, several lines of evidence point to the possibility that clock genes may have a significant impact on the development and progression of the disease. This review aims to consolidate recent understanding of the roles of clock genes in PD. We first summarized the findings of clock gene expression and epigenetic analyses in PD patients and animal models. We also discussed the potential contributory role of clock gene variants in the development of PD and/or its symptoms. We further reviewed the mechanisms by which clock genes affect mitochondrial dynamics as well as the rhythmic synthesis and secretion of endocrine hormones, the impairment of which may contribute to the development of PD. Finally, we discussed the limitations of the currently available studies, and suggested future potential studies to deepen our understanding of the roles of clock genes in PD pathogenesis.
Copyright © 2022 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clock genes; Epigenetics; Genetic polymorphisms; Hormonal destabilization; Mitochondrial dynamics; Parkinson’s disease

Mesh:

Year:  2021        PMID: 34973458     DOI: 10.1016/j.arr.2021.101554

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  6 in total

1.  Altered Motor Performance, Sleep EEG, and Parkinson's Disease Pathology Induced by Chronic Sleep Deprivation in Lrrk2G2019S Mice.

Authors:  Xinyao Liu; Hang Yu; Yuanyuan Wang; Song Li; Cheng Cheng; Murad Al-Nusaif; Weidong Le
Journal:  Neurosci Bull       Date:  2022-05-25       Impact factor: 5.271

Review 2.  Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression.

Authors:  Dmytro I Boiko; Anastasiia D Shkodina; Mohammad Mehedi Hasan; Mainak Bardhan; Syeda Kanza Kazmi; Hitesh Chopra; Prerna Bhutra; Atif Amin Baig; Andrii M Skrypnikov
Journal:  Neurochem Res       Date:  2022-06-11       Impact factor: 4.414

Review 3.  Hepatitis B and circadian rhythm of the liver.

Authors:  Ivana Skrlec; Jasminka Talapko
Journal:  World J Gastroenterol       Date:  2022-07-21       Impact factor: 5.374

Review 4.  NADPH and Mitochondrial Quality Control as Targets for a Circadian-Based Fasting and Exercise Therapy for the Treatment of Parkinson's Disease.

Authors:  William M Curtis; William A Seeds; Mark P Mattson; Patrick C Bradshaw
Journal:  Cells       Date:  2022-08-04       Impact factor: 7.666

5.  Effect of Scalp Nerve Block Combined with Intercostal Nerve Block on the Quality of Recovery in Patients with Parkinson's Disease after Deep Brain Stimulation: Protocol for a Randomized Controlled Trial.

Authors:  Ying Sheng; Hui Wang; Xinning Chang; Peipei Jin; Shengwei Lin; Shuang Qian; Jian Xie; Wenbin Lu; Xiya Yu
Journal:  Brain Sci       Date:  2022-07-29

Review 6.  Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer's disease.

Authors:  Ibtisam Mumtaz; Mir Owais Ayaz; Mohamad Sultan Khan; Umar Manzoor; Mohd Azhardin Ganayee; Aadil Qadir Bhat; Ghulam Hassan Dar; Badrah S Alghamdi; Anwar M Hashem; Mohd Jamal Dar; Gulam Md Ashraf; Tariq Maqbool
Journal:  Front Aging Neurosci       Date:  2022-09-07       Impact factor: 5.702

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.